Hemostemix Inc : Hemostemix Announces Five Million Unit Private Placement finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Hemostemix Inc.: Hemostemix Announces Warrant Repricing and Extension
Calgary, Alberta (Newsfile Corp. - July 5, 2021) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (FSE: 2VFO) ( Hemostemix or the Company ) is pleased to announce, subject to TSX Venture Exchange Approval, that it has extended for two years and repriced to $0.55 from $1, subject to the accelerator provisions stated below on all repriced warrants, 1,332,500 Warrants expiring July 9, 2021; extended 918,450 Warrants expiring November 24, 2021 of which 510,295 Warrants are repriced to $0.55 (408,155 Warrants held by insiders not repriced from $1); extended 6,360,585 Warrants expiring December 18, 2021, repricing 4,733,559 Warrants (1,627,026 Warrants held by insiders are not repriced from $1); extended 9,166,667 Warrants expiring December 31, 2021, repricing 8,513,334 Warrants (653,333 Warrants held by insiders not repriced from $1).
Hemostemix to Present at the Emerging Growth Conference streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Hemostemix Inc.: Hemostemix to Present at the Emerging Growth Conference
Hemostemix or the
Company ) is pleased to announce that it will present live at the Emerging Growth Conference on May 26, 2021 from 3:30 - 4:00 ET and it invites shareholders, individual and institutional investors, as well as advisors and analysts to attend its real-time, interactive presentation.
Attendees are invited to register here to ensure you are able to attend the conference and receive any updates that are released.
ABOUT EMERGING GROWHT CONFERENCE
The Emerging Growth conference is an effective way for public companies to present and communicate their new products, services and other major announcements to the investment community from the convenience of their office, in a time efficient manner.
Hemostemix Inc.: Hemostemix Announces Closing of Unit Private Placement
Hemostemix or the
Units ) announced on April 9, 2021, for gross proceeds of $440,031.90 (the
Offering ). The Offering consisted of the issuance of an aggregate of 1,257,234 Units at a price of $0.35 per Unit. Each Unit consists of one common share in the capital of the Company (
Common Share ) and one transferable common share purchase warrant (
Warrant ), with each full Warrant entitling the holder to acquire one Common Share at a price of $0.40 per Common Share for a period of 24 months from the closing of the Offering, subject to the accelerated expiry provision described below.